Pfizer / BioNTech vaccines were first packaged on French soil on Wednesday in a move hailed by President Emmanuel Macron as an important step as the country seeks to increase its vaccination campaign.
The French pharmaceutical company Delpharm on Wednesday began packing the vaccines in bottles to be delivered to distribution centers.
“It starts concrete from today with the first BioNTech-Pfizer vaccines produced at the Delpharm plant in Saint-Rémy-sur-Avre” north of Paris, “Macron said on Twitter. “250 million doses of Covid-19 vaccines manufactured in France in 2021: that is our goal,” he added.
250 million doses of vaccines Covid-19 products in France in 2021: voilà notre objective. This starts concretely from today with the first BioNTech-Pfizer-vaccines products on the Delpharm de Saint-Rémy-sur-Avre site: congratulations to all the teams!
– Emmanuel Macron (@EmmanuelMacron) April 7, 2021
The vaccines were manufactured in BioNTech’s factory in Germany and delivered to France on Tuesday for packaging and distribution.
They are not just for France, and Delpharm tells AFP that the country would get its share of allotted doses among EU states, set at about 15 percent.
Employees at the Delpharm plant in Saint-Rémy-sur-Avre said production had increased in recent months with the company employing about 60 additional workers on site, a welcome development in the northern French city.
Another company will start submitting Modern vaccines in central France in a few days, and Johnson & Johnson and CureVac vaccines will follow shortly.
French authorities have been criticized for the slow expansion of vaccines in the country, with 14.2 percent of French people receiving one or more doses, compared to 60.1 percent of Britons.
( Jowharwith AFP)